The company will use the proceeds from the investment, which was in addition to the $25m capital round MAP announced closing in March headed by Aetna, a CVS Health Business, to expand its provider network which currently consists of several hundred addiction treatment providers who operate 8,000 beds.
Led by Founder and CEO, Jacob Levenson, MAP focuses on improving and measuring post-treatment clinical outcomes primarily through the implementation of longer-term support. The personalized support is conducted via phone or video sessions by certified peer recovery specialists who leverage both lived experience in recovery and extensive training to engage and support individuals and their families through the difficult and lengthy transition from treatment to long-term recovery.
MAP is working with the nation’s leading health insurance companies and treatment providers.
FinSMEs
23/05/2019